Mom Battles Kidney Disease Her Whole Life—Then Her Son Changes Everything
According to the American Kidney Fund, kidney disease is growing at an alarming rate. It currently affects more than one in ...
NKF's KidneyCAREâ„¢ Study Celebrates One-Year Milestone, Enrolling Over 1,000 Patients Nationwide
The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)™ Study – ...
Morningstar6d
NKF's KidneyCAREâ„¢ Study Celebrates One-Year Milestone, Enrolling Over 1,000 Patients Nationwide
The Registry includes individuals with a wide range of kidney conditions, from diabetes and hypertension – the most common causes of ... (C3G), Focal Segmental Glomerulosclerosis (FSGS ...
WebMD6d
What to Expect as IgA Nephropathy Progresses
Aside from chronic kidney failure and end-stage renal disease, IgA can cause other challenges. Learn more about kidney transplant issues, heart risks, and more.
BioWorld1d
CR1 variants tied to focal segmental glomerulosclerosis, study shows
Focal segmental glomerulosclerosis (FSGS) is a kidney disease that leads to renal failure, and it affects individuals from different ancestries, the highest prevalence being among African and African ...
Suni Lee Pens Emotional Essay About Her Incurable Kidney Disease: 'I Will Never Be the Same Suni'
Olympic gymnast Suni Lee detailed her emotional battle with an incurable kidney disease in a new essay for 'Women's Health' ...
BioSpace4d
Novartis’ Fabhalta Approved as First Therapy for Rare Kidney Disease
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...
Fierce Pharma4d
Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...